<![CDATA[BioLegend 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=15149>Thu, 30 Apr 2026 03:55:52 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[BioLegend Enters License Agreement with Sanquin for Peptide-MHC Assay Technology]]>https://www.newswire.co.kr/newsRead.php?no=829450Fri, 24 Jun 2016 10:10:00 +0900<![CDATA[BioLegend, 상킨과 펩타이드-MHC 분석기술 라이선스계약 체결]]>https://www.newswire.co.kr/newsRead.php?no=829451Fri, 24 Jun 2016 10:10:00 +0900<![CDATA[BioLegend, ISO 9001:2008 alc ISO 13485:2003 인증 받다]]>https://www.newswire.co.kr/newsRead.php?no=683249Fri, 08 Mar 2013 15:07:26 +0900<![CDATA[BioLegend Receives ISO 9001:2008 and ISO 13485:2003 Certification]]>https://www.newswire.co.kr/newsRead.php?no=683248Fri, 08 Mar 2013 15:05:43 +0900<![CDATA[BioLegend Releases Brilliant Violet 421(TM) Antibody Conjugates for Advanced Flow Cytometry Applications]]>https://www.newswire.co.kr/newsRead.php?no=539009Fri, 15 Apr 2011 14:44:45 +0900<![CDATA[BioLegend, 첨단 흐름세포측정 적용 위한 ‘Brilliant Violet 421’ 항체 복합체 출시]]>https://www.newswire.co.kr/newsRead.php?no=539007Fri, 15 Apr 2011 14:43:55 +0900